Showing results (911-920 of 2,061) with videos related to

Sort By:
Pageof 207
Brachytherapy|May 20, 2014
3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomesJordan Kharofa, Natalya Morrow, Tracy Kelly, et al.
Brachytherapy|November 11, 2022
Feasibility of collagen matrix tiles with cesium-131 brachytherapy for use in the treatment of head and neck cancerAarti Agarwal, Joseph Pinto, Bryan Renslo, et al.
Brachytherapy|August 4, 2022
Results of computer tomography-based adaptive brachytherapy in combination with whole-pelvic- and central-shielding-external beam radiotherapy for cervical cancerTomomi Aoshika, Shin-Ei Noda, Takanori Abe, et al.
Brachytherapy|August 1, 2022
Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancerAnupam Rishi, Amarjit S Saini, Philippe E Spiess, et al.
Brachytherapy|March 7, 2023
Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: Methodological development of sigmoid points through virtual endoscopic methodArpita Bindal, Prachi Mittal, Abhishek Shinghal, et al.
Brachytherapy|November 14, 2022
HDR brachytherapy in keratinocyte skin carcinomas - Single center experience with analysis of clinical, dosimetric, and radiobiological factors in acute skin toxicitySilvia Rodríguez Villalba, Damian Guirado LLorente, Alberto Sanz Cazorla, et al.
Brachytherapy|November 22, 2025
MRI-guided brachytherapy for vaginal recurrence of endometrial cancerJuliet Maina, Zhihui Amy Liu, Michael Milosevic, et al.
Brachytherapy|November 16, 2025
AI-assisted 3D-printed transvaginal template guidance for interstitial brachytherapy in patients with cervical cancer with parametrial invasionHuiling Li, Xiuhua Li, Jianqiu Zhang, et al.
Brachytherapy|November 12, 2025
Multicenter study on mechanical accuracy of short dwell time and source transit for HDR Ir-192 brachytherapy treatment machineYoshihiro Ueda, Hiroyuki Okamoto, Yoshifumi Oku, et al.
Brachytherapy|January 6, 2026
Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103Martin King, Grgur Mirić, Mutlay Sayan, et al.
Pageof 207